Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,756 across all filing types
Latest filing 2025-07-28 AGM Information
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Proceedings of 52nd AGM held on 28-jul-25
AGM Information Classification · 95% confidence The document is a letter addressed to the stock exchanges reporting the proceedings of the 52nd Annual General Meeting (AGM) held on 28th July 2025. It lists the business transacted at the AGM, including approval of financial statements, dividend declarations, director appointments, remuneration approvals, borrowing limits, and other corporate actions. It also mentions that voting results will be disclosed separately. The document is a summary of the AGM proceedings rather than the full AGM materials or presentations. The length is under 5,000 characters and it is a formal communication of the AGM outcomes. Therefore, it fits the category of AGM Information (AGM-R) which covers presentations and materials shared during the AGM or summaries of the meeting proceedings.
2025-07-28 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a communication addressed to the stock exchanges regarding the proceedings of the 52nd Annual General Meeting (AGM) held on 28th July 2025. It lists the business transacted at the AGM, including approval of financial statements, dividend declarations, director appointments, remuneration approvals, borrowing limits, and other corporate actions. The document is not the full AGM presentation or materials but a summary of the proceedings. It also mentions that the declaration of voting results and scrutinizer's report will be disclosed separately. The document length is 3881 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or summaries of AGM proceedings.
2025-07-28 English
Outcome of Board Meeting
Regulatory Filings
2025-07-28 English
Press Release
Regulatory Filings
2025-07-28 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding a presentation to analysts on unaudited consolidated financial results for the quarter ended 30th June 2025. It includes summary revenue data for Q1 FY 2025-26. The document is short (1609 characters) and explicitly states it is a presentation to analysts, not the full financial report itself. This matches the definition of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. It is not an earnings release (ER) because it contains more detailed data and is presented as a presentation. It is not a full interim report (IR) because it is a presentation, not a comprehensive report with full financial statements. Therefore, the correct classification is Investor Presentation (IP).
2025-07-28 English
Outcome of Board Meeting
Regulatory Filings
2025-07-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.